GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RaySearch Laboratories AB (OSTO:RAY B) » Definitions » EV-to-EBITDA

RaySearch Laboratories AB (OSTO:RAY B) EV-to-EBITDA : 35.45 (As of Jun. 16, 2024)


View and export this data going back to 1991. Start your Free Trial

What is RaySearch Laboratories AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, RaySearch Laboratories AB's enterprise value is kr5,029 Mil. RaySearch Laboratories AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was kr142 Mil. Therefore, RaySearch Laboratories AB's EV-to-EBITDA for today is 35.45.

The historical rank and industry rank for RaySearch Laboratories AB's EV-to-EBITDA or its related term are showing as below:

OSTO:RAY B' s EV-to-EBITDA Range Over the Past 10 Years
Min: -4052.82   Med: 34.6   Max: 8801.93
Current: 35.45

During the past 13 years, the highest EV-to-EBITDA of RaySearch Laboratories AB was 8801.93. The lowest was -4052.82. And the median was 34.60.

OSTO:RAY B's EV-to-EBITDA is ranked worse than
87.96% of 465 companies
in the Healthcare Providers & Services industry
Industry Median: 12.64 vs OSTO:RAY B: 35.45

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-16), RaySearch Laboratories AB's stock price is kr144.20. RaySearch Laboratories AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr2.939. Therefore, RaySearch Laboratories AB's PE Ratio for today is 49.06.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


RaySearch Laboratories AB EV-to-EBITDA Historical Data

The historical data trend for RaySearch Laboratories AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaySearch Laboratories AB EV-to-EBITDA Chart

RaySearch Laboratories AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.79 13.19 12.14 8.00 8.08

RaySearch Laboratories AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.43 32.33 32.94 8.08 28.39

Competitive Comparison of RaySearch Laboratories AB's EV-to-EBITDA

For the Health Information Services subindustry, RaySearch Laboratories AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's EV-to-EBITDA falls into.



RaySearch Laboratories AB EV-to-EBITDA Calculation

RaySearch Laboratories AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=5028.985/141.867
=35.45

RaySearch Laboratories AB's current Enterprise Value is kr5,029 Mil.
RaySearch Laboratories AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr142 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RaySearch Laboratories AB  (OSTO:RAY B) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

RaySearch Laboratories AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=144.20/2.939
=49.06

RaySearch Laboratories AB's share price for today is kr144.20.
RaySearch Laboratories AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr2.939.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


RaySearch Laboratories AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of RaySearch Laboratories AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


RaySearch Laboratories AB (OSTO:RAY B) Business Description

Traded in Other Exchanges
Address
Sveavagen 44, P.O. Box 3297, Stockholm, SWE, 103 65
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.

RaySearch Laboratories AB (OSTO:RAY B) Headlines

No Headlines